Retatrutide Compounding: Will Pharmacies Make It?
The outlook for compounded retatrutide -- before and after FDA approval.
The affordability revolution in GLP-1 medications -- driven by compounding pharmacies producing semaglutide and tirzepatide at a fraction of brand-name cost -- raises a key question for the next generation: will compounding pharmacies make retatrutide?
Current Status: Pre-Approval Compounding
Right now, retatrutide occupies a unique legal position. It is not yet FDA-approved as a brand-name product, which means it is not subject to brand-name patent protections in the same way. Compounding pharmacies can produce retatrutide peptide through solid-phase synthesis for clinical use under physician supervision. Trimi currently offers this pathway with quality-verified sourcing and third-party testing.
Post-Approval Scenarios
Quality Standards for Compounded Retatrutide
What to Look for in Compounded Retatrutide
- Certificate of analysis: Third-party testing for identity, purity, potency
- Purity greater than 95%: Verified by HPLC analysis
- Sterility testing: Confirmed absence of microbial contamination
- Physician oversight: Close monitoring given investigational status
- Proper storage: Refrigerated with stability data
Access Retatrutide Today
Do not wait for brand-name approval. Trimi offers compounded retatrutide alongside semaglutide ($99/mo) and tirzepatide ($125/mo).
Explore TreatmentsMedical Disclaimer
Retatrutide is investigational and not FDA-approved. Compounding regulations can change. This article is for informational purposes. Consult your healthcare provider.
More on retatrutide
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).